0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insomnia Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-37H5901
Home | Market Reports | Health| Health Conditions| Sleep Disorders
Global Insomnia Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Insomnia Market Insights, Forecast to 2029

Code: QYRE-Auto-37H5901
Report
August 2023
Pages:94
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Insomnia Market Size

The global Insomnia market is projected to grow from US$ 4152.4 million in 2023 to US$ 5074.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.

Insomnia Market

Insomnia Market

Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.
Market Analysis and Insights: Global Insomnia Market
Sleep hygiene and lifestyle changes are typically the first treatment for insomnia. Sleep hygiene includes a consistent bedtime, exposure to sunlight, a quiet and dark room, and regular exercise. Cognitive behavioral therapy may be added to this. While sleeping pills may help, they are associated with injuries, dementia, and addiction.
Report Includes
This report presents an overview of global market for Insomnia market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Insomnia, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Insomnia, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Insomnia revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Insomnia market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Insomnia revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics and Purdue Pharmaceuticals, etc.

Scope of Insomnia Market Report

Report Metric Details
Report Name Insomnia Market
Accounted market size in 2023 US$ 4152.4 million
Forecasted market size in 2029 US$ 5074.9 million
CAGR 3.4
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Pharmacological Therapy
  • Non-pharmacological Therapy
Segment by Application
  • Female
  • Male
  • Senior Citizens
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics, Purdue Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Insomnia in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Insomnia companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insomnia revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Insomnia Market growing?

Ans: The Insomnia Market witnessing a CAGR of 3.4 during the forecast period 2023-2029.

What is the Insomnia Market size in 2029?

Ans: The global Insomnia market is projected to grow from US$ 4152.4 million in 2023 to US$ 5074.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.

Who are the main players in the Insomnia Market report?

Ans: The main players in the Insomnia Market are Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics, Purdue Pharmaceuticals

What are the Application segmentation covered in the Insomnia Market report?

Ans: The Applications covered in the Insomnia Market report are Female, Male, Senior Citizens

What are the Type segmentation covered in the Insomnia Market report?

Ans: The Types covered in the Insomnia Market report are Pharmacological Therapy, Non-pharmacological Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Pharmacological Therapy
1.2.3 Non-pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Female
1.3.3 Male
1.3.4 Senior Citizens
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Market Perspective (2018-2029)
2.2 Global Insomnia Growth Trends by Region
2.2.1 Insomnia Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Insomnia Historic Market Size by Region (2018-2023)
2.2.3 Insomnia Forecasted Market Size by Region (2024-2029)
2.3 Insomnia Market Dynamics
2.3.1 Insomnia Industry Trends
2.3.2 Insomnia Market Drivers
2.3.3 Insomnia Market Challenges
2.3.4 Insomnia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Insomnia by Players
3.1.1 Global Insomnia Revenue by Players (2018-2023)
3.1.2 Global Insomnia Revenue Market Share by Players (2018-2023)
3.2 Global Insomnia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Insomnia, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Insomnia Market Concentration Ratio
3.4.1 Global Insomnia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Revenue in 2022
3.5 Global Key Players of Insomnia Head office and Area Served
3.6 Global Key Players of Insomnia, Product and Application
3.7 Global Key Players of Insomnia, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Breakdown Data by Type
4.1 Global Insomnia Historic Market Size by Type (2018-2023)
4.2 Global Insomnia Forecasted Market Size by Type (2024-2029)
5 Insomnia Breakdown Data by Application
5.1 Global Insomnia Historic Market Size by Application (2018-2023)
5.2 Global Insomnia Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Insomnia Market Size (2018-2029)
6.2 North America Insomnia Market Size by Type
6.2.1 North America Insomnia Market Size by Type (2018-2023)
6.2.2 North America Insomnia Market Size by Type (2024-2029)
6.2.3 North America Insomnia Market Share by Type (2018-2029)
6.3 North America Insomnia Market Size by Application
6.3.1 North America Insomnia Market Size by Application (2018-2023)
6.3.2 North America Insomnia Market Size by Application (2024-2029)
6.3.3 North America Insomnia Market Share by Application (2018-2029)
6.4 North America Insomnia Market Size by Country
6.4.1 North America Insomnia Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Insomnia Market Size by Country (2018-2023)
6.4.3 North America Insomnia Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Insomnia Market Size (2018-2029)
7.2 Europe Insomnia Market Size by Type
7.2.1 Europe Insomnia Market Size by Type (2018-2023)
7.2.2 Europe Insomnia Market Size by Type (2024-2029)
7.2.3 Europe Insomnia Market Share by Type (2018-2029)
7.3 Europe Insomnia Market Size by Application
7.3.1 Europe Insomnia Market Size by Application (2018-2023)
7.3.2 Europe Insomnia Market Size by Application (2024-2029)
7.3.3 Europe Insomnia Market Share by Application (2018-2029)
7.4 Europe Insomnia Market Size by Country
7.4.1 Europe Insomnia Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Insomnia Market Size by Country (2018-2023)
7.4.3 Europe Insomnia Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Insomnia Market Size (2018-2029)
8.2 China Insomnia Market Size by Type
8.2.1 China Insomnia Market Size by Type (2018-2023)
8.2.2 China Insomnia Market Size by Type (2024-2029)
8.2.3 China Insomnia Market Share by Type (2018-2029)
8.3 China Insomnia Market Size by Application
8.3.1 China Insomnia Market Size by Application (2018-2023)
8.3.2 China Insomnia Market Size by Application (2024-2029)
8.3.3 China Insomnia Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Insomnia Market Size (2018-2029)
9.2 Asia Insomnia Market Size by Type
9.2.1 Asia Insomnia Market Size by Type (2018-2023)
9.2.2 Asia Insomnia Market Size by Type (2024-2029)
9.2.3 Asia Insomnia Market Share by Type (2018-2029)
9.3 Asia Insomnia Market Size by Application
9.3.1 Asia Insomnia Market Size by Application (2018-2023)
9.3.2 Asia Insomnia Market Size by Application (2024-2029)
9.3.3 Asia Insomnia Market Share by Application (2018-2029)
9.4 Asia Insomnia Market Size by Region
9.4.1 Asia Insomnia Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Insomnia Market Size by Region (2018-2023)
9.4.3 Asia Insomnia Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Insomnia Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Insomnia Market Size by Type
10.2.1 Middle East, Africa, and Latin America Insomnia Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Insomnia Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Insomnia Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Insomnia Market Size by Application
10.3.1 Middle East, Africa, and Latin America Insomnia Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Insomnia Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Insomnia Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Insomnia Market Size by Country
10.4.1 Middle East, Africa, and Latin America Insomnia Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Insomnia Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Insomnia Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Insomnia Introduction
11.1.4 Merck Revenue in Insomnia Business (2018-2023)
11.1.5 Merck Recent Developments
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Insomnia Introduction
11.2.4 Eisai Revenue in Insomnia Business (2018-2023)
11.2.5 Eisai Recent Developments
11.3 Meda Consumer Healthcare
11.3.1 Meda Consumer Healthcare Company Details
11.3.2 Meda Consumer Healthcare Business Overview
11.3.3 Meda Consumer Healthcare Insomnia Introduction
11.3.4 Meda Consumer Healthcare Revenue in Insomnia Business (2018-2023)
11.3.5 Meda Consumer Healthcare Recent Developments
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Details
11.4.2 Takeda Pharmaceuticals Business Overview
11.4.3 Takeda Pharmaceuticals Insomnia Introduction
11.4.4 Takeda Pharmaceuticals Revenue in Insomnia Business (2018-2023)
11.4.5 Takeda Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Insomnia Introduction
11.5.4 Pfizer Revenue in Insomnia Business (2018-2023)
11.5.5 Pfizer Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Insomnia Introduction
11.6.4 Sanofi Revenue in Insomnia Business (2018-2023)
11.6.5 Sanofi Recent Developments
11.7 Vanda Pharmaceuticals
11.7.1 Vanda Pharmaceuticals Company Details
11.7.2 Vanda Pharmaceuticals Business Overview
11.7.3 Vanda Pharmaceuticals Insomnia Introduction
11.7.4 Vanda Pharmaceuticals Revenue in Insomnia Business (2018-2023)
11.7.5 Vanda Pharmaceuticals Recent Developments
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Business (2018-2023)
11.8.5 Pernix Therapeutics Recent Developments
11.9 Purdue Pharmaceuticals
11.9.1 Purdue Pharmaceuticals Company Details
11.9.2 Purdue Pharmaceuticals Business Overview
11.9.3 Purdue Pharmaceuticals Insomnia Introduction
11.9.4 Purdue Pharmaceuticals Revenue in Insomnia Business (2018-2023)
11.9.5 Purdue Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Insomnia Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Pharmacological Therapy
    Table 3. Key Players of Non-pharmacological Therapy
    Table 4. Global Insomnia Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 5. Global Insomnia Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Insomnia Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Insomnia Market Share by Region (2018-2023)
    Table 8. Global Insomnia Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Insomnia Market Share by Region (2024-2029)
    Table 10. Insomnia Market Trends
    Table 11. Insomnia Market Drivers
    Table 12. Insomnia Market Challenges
    Table 13. Insomnia Market Restraints
    Table 14. Global Insomnia Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Insomnia Revenue Share by Players (2018-2023)
    Table 16. Global Top Insomnia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia as of 2022)
    Table 17. Global Insomnia Industry Ranking 2021 VS 2022 VS 2023
    Table 18. Global 5 Largest Players Market Share by Insomnia Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Global Key Players of Insomnia, Headquarters and Area Served
    Table 20. Global Key Players of Insomnia, Product and Application
    Table 21. Global Key Players of Insomnia, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Insomnia Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Insomnia Revenue Market Share by Type (2018-2023)
    Table 25. Global Insomnia Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Insomnia Revenue Market Share by Type (2024-2029)
    Table 27. Global Insomnia Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Insomnia Revenue Share by Application (2018-2023)
    Table 29. Global Insomnia Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Insomnia Revenue Share by Application (2024-2029)
    Table 31. North America Insomnia Market Size by Type (2018-2023) & (US$ Million)
    Table 32. North America Insomnia Market Size by Type (2024-2029) & (US$ Million)
    Table 33. North America Insomnia Market Size by Application (2018-2023) & (US$ Million)
    Table 34. North America Insomnia Market Size by Application (2024-2029) & (US$ Million)
    Table 35. North America Insomnia Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Insomnia Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Insomnia Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Insomnia Market Size by Type (2018-2023) & (US$ Million)
    Table 39. Europe Insomnia Market Size by Type (2024-2029) & (US$ Million)
    Table 40. Europe Insomnia Market Size by Application (2018-2023) & (US$ Million)
    Table 41. Europe Insomnia Market Size by Application (2024-2029) & (US$ Million)
    Table 42. Europe Insomnia Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Europe Insomnia Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Europe Insomnia Market Size by Country (2024-2029) & (US$ Million)
    Table 45. China Insomnia Market Size by Type (2018-2023) & (US$ Million)
    Table 46. China Insomnia Market Size by Type (2024-2029) & (US$ Million)
    Table 47. China Insomnia Market Size by Application (2018-2023) & (US$ Million)
    Table 48. China Insomnia Market Size by Application (2024-2029) & (US$ Million)
    Table 49. Asia Insomnia Market Size by Type (2018-2023) & (US$ Million)
    Table 50. Asia Insomnia Market Size by Type (2024-2029) & (US$ Million)
    Table 51. Asia Insomnia Market Size by Application (2018-2023) & (US$ Million)
    Table 52. Asia Insomnia Market Size by Application (2024-2029) & (US$ Million)
    Table 53. Asia Insomnia Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 54. Asia Insomnia Market Size by Region (2018-2023) & (US$ Million)
    Table 55. Asia Insomnia Market Size by Region (2024-2029) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Insomnia Market Size by Type (2018-2023) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Insomnia Market Size by Type (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Insomnia Market Size by Application (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Insomnia Market Size by Application (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Insomnia Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 61. Middle East, Africa, and Latin America Insomnia Market Size by Country (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Insomnia Market Size by Country (2024-2029) & (US$ Million)
    Table 63. Merck Company Details
    Table 64. Merck Business Overview
    Table 65. Merck Insomnia Product
    Table 66. Merck Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 67. Merck Recent Developments
    Table 68. Eisai Company Details
    Table 69. Eisai Business Overview
    Table 70. Eisai Insomnia Product
    Table 71. Eisai Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 72. Eisai Recent Developments
    Table 73. Meda Consumer Healthcare Company Details
    Table 74. Meda Consumer Healthcare Business Overview
    Table 75. Meda Consumer Healthcare Insomnia Product
    Table 76. Meda Consumer Healthcare Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 77. Meda Consumer Healthcare Recent Developments
    Table 78. Takeda Pharmaceuticals Company Details
    Table 79. Takeda Pharmaceuticals Business Overview
    Table 80. Takeda Pharmaceuticals Insomnia Product
    Table 81. Takeda Pharmaceuticals Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 82. Takeda Pharmaceuticals Recent Developments
    Table 83. Pfizer Company Details
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Insomnia Product
    Table 86. Pfizer Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 87. Pfizer Recent Developments
    Table 88. Sanofi Company Details
    Table 89. Sanofi Business Overview
    Table 90. Sanofi Insomnia Product
    Table 91. Sanofi Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 92. Sanofi Recent Developments
    Table 93. Vanda Pharmaceuticals Company Details
    Table 94. Vanda Pharmaceuticals Business Overview
    Table 95. Vanda Pharmaceuticals Insomnia Product
    Table 96. Vanda Pharmaceuticals Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 97. Vanda Pharmaceuticals Recent Developments
    Table 98. Pernix Therapeutics Company Details
    Table 99. Pernix Therapeutics Business Overview
    Table 100. Pernix Therapeutics Insomnia Product
    Table 101. Pernix Therapeutics Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 102. Pernix Therapeutics Recent Developments
    Table 103. Purdue Pharmaceuticals Company Details
    Table 104. Purdue Pharmaceuticals Business Overview
    Table 105. Purdue Pharmaceuticals Insomnia Product
    Table 106. Purdue Pharmaceuticals Revenue in Insomnia Business (2018-2023) & (US$ Million)
    Table 107. Purdue Pharmaceuticals Recent Developments
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Insomnia Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Insomnia Market Share by Type: 2022 VS 2029
    Figure 3. Pharmacological Therapy Features
    Figure 4. Non-pharmacological Therapy Features
    Figure 5. Global Insomnia Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 6. Global Insomnia Market Share by Application: 2022 VS 2029
    Figure 7. Female Case Studies
    Figure 8. Male Case Studies
    Figure 9. Senior Citizens Case Studies
    Figure 10. Insomnia Report Years Considered
    Figure 11. Global Insomnia Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Insomnia Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Insomnia Market Share by Region: 2022 VS 2029
    Figure 14. Global Insomnia Market Share by Players in 2022
    Figure 15. Global Top Insomnia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Insomnia Revenue in 2022
    Figure 17. North America Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Insomnia Market Share by Type (2018-2029)
    Figure 19. North America Insomnia Market Share by Application (2018-2029)
    Figure 20. North America Insomnia Market Share by Country (2018-2029)
    Figure 21. United States Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Insomnia Market Size YoY (2018-2029) & (US$ Million)
    Figure 24. Europe Insomnia Market Share by Type (2018-2029)
    Figure 25. Europe Insomnia Market Share by Application (2018-2029)
    Figure 26. Europe Insomnia Market Share by Country (2018-2029)
    Figure 27. Germany Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. China Insomnia Market Size YoY (2018-2029) & (US$ Million)
    Figure 34. China Insomnia Market Share by Type (2018-2029)
    Figure 35. China Insomnia Market Share by Application (2018-2029)
    Figure 36. Asia Insomnia Market Size YoY (2018-2029) & (US$ Million)
    Figure 37. Asia Insomnia Market Share by Type (2018-2029)
    Figure 38. Asia Insomnia Market Share by Application (2018-2029)
    Figure 39. Asia Insomnia Market Share by Region (2018-2029)
    Figure 40. Japan Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. South Korea Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. China Taiwan Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Southeast Asia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. India Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Australia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Insomnia Market Size YoY (2018-2029) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Insomnia Market Share by Type (2018-2029)
    Figure 48. Middle East, Africa, and Latin America Insomnia Market Share by Application (2018-2029)
    Figure 49. Middle East, Africa, and Latin America Insomnia Market Share by Country (2018-2029)
    Figure 50. Brazil Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Mexico Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Turkey Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Israel Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. GCC Countries Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Merck Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 57. Eisai Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 58. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 59. Takeda Pharmaceuticals Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 60. Pfizer Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 61. Sanofi Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 62. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 63. Pernix Therapeutics Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 64. Purdue Pharmaceuticals Revenue Growth Rate in Insomnia Business (2018-2023)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS